Dror Ortho-Design NT 10-Q: late Q3 2025 filing notice

Dror Ortho-Design, Inc. has filed a Form 12b-25 to notify the SEC and investors that its Quarterly Report on Form 10-Q for the nine months ended September 30, 2025 will be filed late.

Rhea-AI Filing Summary

Dror Ortho-Design, Inc. has filed a Form 12b-25 to notify the SEC and investors that its Quarterly Report on Form 10-Q for the nine months ended September 30, 2025 will be filed late. The company states it cannot meet the original deadline without unreasonable effort and expense because it needs more time to complete and finalize the financial statements required in the report.

The company indicates that it currently anticipates filing the Form 10-Q on or before the fifth calendar day following the prescribed due date, consistent with the timing relief available under Rule 12b-25 for quarterly reports.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did DROR file a Form 12b-25 for its Q3 2025 10-Q?

Dror Ortho-Design, Inc. filed Form 12b-25 because it could not file its Form 10-Q for the nine months ended September 30, 2025 by the original deadline without unreasonable effort and expense, and needs additional time to complete and finalize its financial statements.

Which reporting period is covered by DROR's delayed Form 10-Q?

The delayed Form 10-Q for Dror Ortho-Design, Inc. covers the nine-month period ended September 30, 2025.

When does DROR expect to file the delayed Form 10-Q?

Dror Ortho-Design, Inc. states that it currently anticipates filing the Form 10-Q on or before the fifth calendar day following the prescribed due date, as permitted for quarterly reports under Rule 12b-25.

What specific form is DROR delaying with this Form 12b-25 notice?

The notice relates to Dror Ortho-Design, Inc.'s Quarterly Report on Form 10-Q for the nine months ended September 30, 2025.

Who signed DROR's Form 12b-25 notification of late filing?

The Form 12b-25 for Dror Ortho-Design, Inc. was signed by Eliyahu (Lee) Haddad, the company’s Chief Executive Officer.

Does the Form 12b-25 state that DROR needs more time for financial statements?

Yes. Dror Ortho-Design, Inc. explains that it requires additional time to complete and finalize the financial statements that must be included in its Form 10-Q, which is the stated reason for the delay.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/17/2025 - 06:10 AM EST Learn about SEC filing dates

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check one):	☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN
	☐ Form N-CSR
	For Period Ended: September 30, 2025

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

For the Transition Period Ended:

_____________________________________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

Dror Ortho-Design, Inc.

Full Name of Registrant

N/A

Former Name if Applicable

Shatner Street 3

Address of Principal Executive Office (Street and Number)

Jerusalem, Israel

City, State and Zip Code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III – NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Dror Ortho-Design, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Quarterly Report on Form 10-Q for the nine months ended September 30, 2025 (the “Form 10-Q”), because the Company requires additional time to complete and finalize its financial statements required to be included in the Form 10-Q. The Company currently anticipates that the Form 10-Q will be filed on or before the fifth calendar day following the prescribed due date.

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Eliyahu (Lee) Haddad		N/A		+972 (0)74-700-6700
(Name)		(Area Code)		(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes ☒ No ☐
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	Yes ☐ No ☒

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

2 

Dror Ortho-Design, Inc.

(Name of registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	November 17, 2025		By:	/s/ Eliyahu (Lee) Haddad
			Name:	Eliyahu (Lee) Haddad
			Title:	Chief Executive Officer

3